Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib. - Wikidata - awgldk - TriplyDB

Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.

Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.

http://www.wikidata.org/entity/Q34028470

about

Steroid Hormone Receptor Signals as Prognosticators for Urothelial Tumor The evolving genomic landscape of urothelial carcinoma.Characteristics and clinical significance of histological variants of bladder cancer.Genomic alterations of ERBB receptors in cancer: clinical implications.

P2860

Q26771960-7D3BF644-BFE2-4BE6-85CE-7C8CD9F46993 Q39124491-D4B1A5DD-D2E0-4C2D-90E9-40C1B6CA57AF Q47998264-33DF7361-8600-4B88-9443-A816B13DE1B6 Q49678076-D2550DB4-BA55-4D06-910C-45FE759F36C9

P2860

Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.

http://www.wikidata.org/entity/Q34028470

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.

@ast

Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.

@en

Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.

@nl

type

label

Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.

@ast

Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.

@en

Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.

@nl

prefLabel

Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.

@ast

Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.

@en

Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.

@nl

P1433

Q34028470-DFAF1182-4093-4CC9-95A0-25E23C27EBF0

P1476

Q34028470-B31DF3CB-E0D0-4994-A77C-B105B1C25696

P2093

Q34028470-0220587F-9604-4D2E-82E4-E15BFB66B74E

Q34028470-02BC8160-3BC6-4A6E-85EE-A76A8C5B686E

Q34028470-5804FCB5-7C24-4D67-A8A7-B1865A9E37B5

Q34028470-636FFA1B-0059-47C2-B118-EB8AE837D51B

Q34028470-7D6686CD-FB7A-49E2-A496-5919F117F3EE

Q34028470-9ED8D18F-66EA-486F-A26A-CE33D38B0EBB

Q34028470-AC30BF5F-4368-425A-81B1-C5CDCC47BF2A

Q34028470-D2EDAAE8-C4CB-4B26-8EFC-EE220E58C392

Q34028470-FD3F546D-2E4C-4A08-A363-283BBC12A31F

P2860

Q34028470-035C7EDD-5BA9-4029-B14E-FA55C916DEBC

Q34028470-06763DBF-37BE-478D-8EB9-DD009CCBFF24

Q34028470-09FFF642-5E40-46CE-9885-1B35BE83579E

Q34028470-0AD171C2-9B5C-464B-A75E-8EF0BF62F457

Q34028470-0E2F042E-F290-4044-B912-AF3181339FB3

Q34028470-0EEA6717-0164-4530-AEBA-11EA488AF753

Q34028470-21D4CF57-10A7-4A81-A476-1B1DCE60D6AE

Q34028470-25633AA9-7A58-4E9D-9BAF-C85DA113C0B0

Q34028470-2E73F74C-E836-4479-910C-DE4EE8D34631

Q34028470-365A45CF-EFFA-4226-B038-D2D5555BEB06

P304

Q34028470-054B5628-53B7-4670-BD14-055949D2C385

P31

Q34028470-36FE99D6-8EF0-4AF8-A927-C775CCA9E000

P356

Q34028470-87BBEB45-9072-4AB0-AD9A-C4725873DAAA

P433

Q34028470-C283B07F-53C1-45F2-AD71-7F191502B391

P478

Q34028470-5169F79E-491B-49BA-9B52-9348E76B20FA

P50

Q34028470-F47B264A-31C3-4722-B5D9-D75F63D68E23

P577

Q34028470-D80C4E21-FC5C-4495-A420-CD6F8A028E0F

P5875

Q34028470-23A051DD-12CB-497E-B0B2-D3B4CD84E2A6

P698

Q34028470-AE8B9971-9631-48A1-991D-3E730ABDBEC4

P932

Q34028470-6B538814-AC76-489C-8DB5-4309FE6BE6E3

P356

P1433

Cancer Biology and Therapy

P1476

Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.

@en

P2093

Dazhong Zhuang

http://www.w3.org/2001/XMLSchema#string

Evanguelos Xylinas

http://www.w3.org/2001/XMLSchema#string

Malte Rieken

http://www.w3.org/2001/XMLSchema#string

Martin Krzywinski

http://www.w3.org/2001/XMLSchema#string

Michela de Martino

http://www.w3.org/2001/XMLSchema#string

Morgan Rouprêt

http://www.w3.org/2001/XMLSchema#string

Shahrokh F Shariat

http://www.w3.org/2001/XMLSchema#string

Thomas Clozel

http://www.w3.org/2001/XMLSchema#string

Tobias Klatte

http://www.w3.org/2001/XMLSchema#string

P2860

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology

Activating HER2 mutations in HER2 gene amplification negative breast cancer

Epithelial-mesenchymal transitions in development and disease

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Cancer statistics, 2013

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I

P304

1239-1247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CBT.29687

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Elemento

P577

2014-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263514735

http://www.w3.org/2001/XMLSchema#string

P698

24971884

http://www.w3.org/2001/XMLSchema#string

P932

4128866

http://www.w3.org/2001/XMLSchema#string